Literature DB >> 25361493

Clinical, radiological, and pathological features in 43 cases of intracranial subependymoma.

Zhiyong Bi1, Xiaohui Ren, Junting Zhang, Wang Jia.   

Abstract

OBJECT: Intracranial subependymomas are rarely reported due to their extremely low incidence. Knowledge about subependymomas is therefore poor. This study aimed to analyze the incidence and clinical, radiological, and pathological features of intracranial subependymomas.
METHODS: Approximately 60,000 intracranial tumors were surgically treated at Beijing Tiantan Hospital between 2003 and 2013. The authors identified all cases in which patients underwent resection of an intracranial tumor that was found to be pathological examination demonstrated to be subependymoma and analyzed the data from these cases.
RESULTS: Forty-three cases of pathologically confirmed, surgically treated intracranial subependymoma were identified. Thus in this patient population, subependymomas accounted for approximately 0.07% of intracranial tumors (43 of an estimated 60,000). Radiologically, 79.1% (34/43) of intracranial subependymomas were misdiagnosed as other diseases. Pathologically, 34 were confirmed as pure subependymomas, 8 were mixed with ependymoma, and 1 was mixed with astrocytoma. Thirty-five patients were followed up for 3.0 to 120 months after surgery. Three of these patients experienced tumor recurrence, and one died of tumor recurrence. Univariate analysis revealed that shorter progression-free survival (PFS) was significantly associated with poorly defined borders. The association between shorter PFS and age < 14 years was almost significant (p = 0.51), and this variable was also included in the multivariate analysis. However, multivariate analysis showed showed only poorly defined borders to be an independent prognostic factor for shorter PFS (RR 18.655, 95% CI 1.141-304.884, p = 0.040). In patients 14 years of age or older, the lesions tended to be pure subependymomas located in the unilateral supratentorial area, total removal tended to be easier, and PFS tended to be longer. In comparison, in younger patients subependymomas tended to be mixed tumors involving the bilateral infratentorial area, with a lower total removal rate and shorter PFS.
CONCLUSIONS: Intracranial subependymoma is a rare benign intracranial tumor with definite radiological features. Long-term survival can be expected, although poorly defined borders are an independent predictor of shorter PFS. All the features that differ between tumors in younger and older patients suggest that they might have different origins, biological behaviors, and prognoses.

Entities:  

Keywords:  CPA = cerebellopontine angle; OS = overall survival; PFS = progression-free survival; SGCA = subependymal giant cell astrocytoma; VP = ventriculoperitoneal; clinical features; oncology; pathology; radiology; subependymoma; survival

Mesh:

Year:  2015        PMID: 25361493     DOI: 10.3171/2014.9.JNS14155

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  20 in total

1.  TRPS1 gene alterations in human subependymoma.

Authors:  Sascha B Fischer; Michelle Attenhofer; Sakir H Gultekin; Donald A Ross; Karl Heinimann
Journal:  J Neurooncol       Date:  2017-05-20       Impact factor: 4.130

Review 2.  Major Features of the 2021 WHO Classification of CNS Tumors.

Authors:  Heather L Smith; Nitin Wadhwani; Craig Horbinski
Journal:  Neurotherapeutics       Date:  2022-05-16       Impact factor: 7.620

3.  Diagnosis of symmetric bilateral lateral ventricular subependymomas: A case report.

Authors:  Nguyen Dinh Minh; Nguyen Duy Hung; Doan-Thi Giang; Ngo Quang Duy; Pham Ngoc Huy; Nguyen Minh Duc
Journal:  Exp Ther Med       Date:  2022-06-08       Impact factor: 2.751

4.  Coexistence of meningioma and other intracranial benign tumors in non-neurofibromatosis type 2 patients: A case report and review of literature.

Authors:  Tian-Hao Hu; Run Wang; Hai-Yun Wang; Yi-Fu Song; Juan-Han Yu; Zi-Xun Wang; Yu-Zhou Duan; Ting Liu; Sheng Han
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

Review 5.  EANO guidelines for the diagnosis and treatment of ependymal tumors.

Authors:  Roberta Rudà; Guido Reifenberger; Didier Frappaz; Stefan M Pfister; Anne Laprie; Thomas Santarius; Patrick Roth; Joerg Christian Tonn; Riccardo Soffietti; Michael Weller; Elizabeth Cohen-Jonathan Moyal
Journal:  Neuro Oncol       Date:  2018-03-27       Impact factor: 12.300

Review 6.  Intracranial ependymomas: The role of advanced neuroimaging in diagnosis and management.

Authors:  Marco Varrassi; Flavia Cobianchi Bellisari; Maria Carmela De Donato; Emanuele Tommasino; Alessandra Di Sibio; Federico Bruno; Hambra Di Vitantonio; Alessandra Splendiani; Ernesto Di Cesare; Carlo Masciocchi
Journal:  Neuroradiol J       Date:  2021-02-01

7.  TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma.

Authors:  Christian Thomas; Felix Thierfelder; Malte Träger; Patrick Soschinski; Michael Müther; Dominic Edelmann; Alexandra Förster; Carola Geiler; Hee-Yeong Kim; Katharina Filipski; Patrick N Harter; Jens Schittenhelm; Franziska Eckert; Georgios Ntoulias; Sven-Axel May; Walter Stummer; Julia Onken; Peter Vajkoczy; Ulrich Schüller; Frank L Heppner; David Capper; Arend Koch; David Kaul; Werner Paulus; Martin Hasselblatt; Leonille Schweizer
Journal:  Acta Neuropathol       Date:  2021-03-23       Impact factor: 17.088

8.  A Case of Intracranial Subependymoma: Histopathological Confirmation of Ring-shaped Lateral Ventricular Nodule.

Authors:  Keita Kuya; Yuki Shinohara; Hiroki Yoshioka; Satoshi Kuwamoto; Masamichi Kurosaki; Toshihide Ogawa
Journal:  Magn Reson Med Sci       Date:  2017-05-22       Impact factor: 2.471

9.  Spinal Cord Subependymoma Surgery : A Multi-Institutional Experience.

Authors:  Woon Tak Yuh; Chun Kee Chung; Sung-Hye Park; Ki-Jeong Kim; Sun-Ho Lee; Kyoung-Tae Kim
Journal:  J Korean Neurosurg Soc       Date:  2018-02-28

10.  Short-term outcome following surgery for rare brain tumor entities in adults: a Swedish nation-wide registry-based study and comparison with SEER database.

Authors:  Jiri Bartek; Sanjay Dhawan; Erik Thurin; Ali Alattar; Sasha Gulati; Bertil Rydenhag; Roger Henriksson; Clark C Chen; Asgeir Store Jakola
Journal:  J Neurooncol       Date:  2020-05-19       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.